nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLC22A7—Fluorouracil—head and neck cancer	0.291	0.413	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Docetaxel—head and neck cancer	0.222	0.315	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Vinblastine—head and neck cancer	0.192	0.272	CbGbCtD
Dinoprost Tromethamine—Ileus paralytic—Vinblastine—head and neck cancer	0.00587	0.0674	CcSEcCtD
Dinoprost Tromethamine—GALR3—head—head and neck cancer	0.00376	0.0644	CbGeAlD
Dinoprost Tromethamine—TBXA2R—epithelium—head and neck cancer	0.00358	0.0614	CbGeAlD
Dinoprost Tromethamine—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.00337	0.0386	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Vinblastine—head and neck cancer	0.00291	0.0334	CcSEcCtD
Dinoprost Tromethamine—PTGER3—connective tissue—head and neck cancer	0.0029	0.0498	CbGeAlD
Dinoprost Tromethamine—HPGDS—connective tissue—head and neck cancer	0.00251	0.043	CbGeAlD
Dinoprost Tromethamine—TBXA2R—thyroid gland—head and neck cancer	0.0025	0.0429	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—neck—head and neck cancer	0.00249	0.0428	CbGeAlD
Dinoprost Tromethamine—HPGDS—epithelium—head and neck cancer	0.00238	0.0409	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—head and neck cancer	0.00225	1	CrCbGaD
Dinoprost Tromethamine—Phlebitis—Vinblastine—head and neck cancer	0.00214	0.0245	CcSEcCtD
Dinoprost Tromethamine—PTGIR—connective tissue—head and neck cancer	0.00205	0.0351	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—parotid gland—head and neck cancer	0.00203	0.0348	CbGeAlD
Dinoprost Tromethamine—PTGER1—head—head and neck cancer	0.00195	0.0335	CbGeAlD
Dinoprost Tromethamine—PTGFR—trachea—head and neck cancer	0.00195	0.0334	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—saliva-secreting gland—head and neck cancer	0.00195	0.0334	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—head and neck cancer	0.00194	0.0333	CbGeAlD
Dinoprost Tromethamine—PTGER3—thyroid gland—head and neck cancer	0.00193	0.0331	CbGeAlD
Dinoprost Tromethamine—Extravasation—Fluorouracil—head and neck cancer	0.00191	0.0219	CcSEcCtD
Dinoprost Tromethamine—HPGDS—lymphoid tissue—head and neck cancer	0.00183	0.0315	CbGeAlD
Dinoprost Tromethamine—Burning sensation—Docetaxel—head and neck cancer	0.00173	0.0199	CcSEcCtD
Dinoprost Tromethamine—PTGER3—head—head and neck cancer	0.00171	0.0293	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—head and neck cancer	0.0017	0.0291	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—head and neck cancer	0.00156	0.0267	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—trachea—head and neck cancer	0.0015	0.0257	CbGeAlD
Dinoprost Tromethamine—HPGDS—head—head and neck cancer	0.00148	0.0254	CbGeAlD
Dinoprost Tromethamine—Sepsis—Fluorouracil—head and neck cancer	0.00145	0.0166	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.0014	0.016	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Docetaxel—head and neck cancer	0.00138	0.0158	CcSEcCtD
Dinoprost Tromethamine—PTGFR—head—head and neck cancer	0.00137	0.0234	CbGeAlD
Dinoprost Tromethamine—PTGIR—thyroid gland—head and neck cancer	0.00136	0.0233	CbGeAlD
Dinoprost Tromethamine—Dysuria—Hydroxyurea—head and neck cancer	0.00136	0.0156	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Hydroxyurea—head and neck cancer	0.00129	0.0149	CcSEcCtD
Dinoprost Tromethamine—Respiratory failure—Docetaxel—head and neck cancer	0.00122	0.0141	CcSEcCtD
Dinoprost Tromethamine—PTGIR—head—head and neck cancer	0.00121	0.0207	CbGeAlD
Dinoprost Tromethamine—Pulmonary embolism—Docetaxel—head and neck cancer	0.0012	0.0138	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—thyroid gland—head and neck cancer	0.0012	0.0206	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—head and neck cancer	0.0012	0.0205	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—thyroid gland—head and neck cancer	0.00119	0.0204	CbGeAlD
Dinoprost Tromethamine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00115	0.0132	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—head—head and neck cancer	0.00106	0.0182	CbGeAlD
Dinoprost Tromethamine—Angiopathy—Hydroxyurea—head and neck cancer	0.00105	0.0121	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—head—head and neck cancer	0.00105	0.0181	CbGeAlD
Dinoprost Tromethamine—Sepsis—Docetaxel—head and neck cancer	0.00104	0.012	CcSEcCtD
Dinoprost Tromethamine—Chills—Hydroxyurea—head and neck cancer	0.00104	0.012	CcSEcCtD
Dinoprost Tromethamine—HPGDS—lymph node—head and neck cancer	0.00104	0.0178	CbGeAlD
Dinoprost Tromethamine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00103	0.0118	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Docetaxel—head and neck cancer	0.00101	0.0116	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00101	0.0116	CcSEcCtD
Dinoprost Tromethamine—Malaise—Vinblastine—head and neck cancer	0.001	0.0115	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000963	0.011	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Vinblastine—head and neck cancer	0.000961	0.011	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Vinblastine—head and neck cancer	0.000958	0.011	CcSEcCtD
Dinoprost Tromethamine—PTGFR—lymph node—head and neck cancer	0.000957	0.0164	CbGeAlD
Dinoprost Tromethamine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000939	0.0108	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Vinblastine—head and neck cancer	0.000933	0.0107	CcSEcCtD
Dinoprost Tromethamine—Malaise—Hydroxyurea—head and neck cancer	0.000913	0.0105	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000906	0.0104	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Fluorouracil—head and neck cancer	0.000879	0.0101	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Hydroxyurea—head and neck cancer	0.000877	0.0101	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Hydroxyurea—head and neck cancer	0.000851	0.00977	CcSEcCtD
Dinoprost Tromethamine—PTGIR—lymph node—head and neck cancer	0.000844	0.0145	CbGeAlD
Dinoprost Tromethamine—Infection—Hydroxyurea—head and neck cancer	0.00082	0.00942	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Vinblastine—head and neck cancer	0.000813	0.00933	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Docetaxel—head and neck cancer	0.000812	0.00932	CcSEcCtD
Dinoprost Tromethamine—Pain—Vinblastine—head and neck cancer	0.000774	0.00889	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Vinblastine—head and neck cancer	0.000746	0.00857	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lymph node—head and neck cancer	0.000745	0.0128	CbGeAlD
Dinoprost Tromethamine—Bronchospasm—Docetaxel—head and neck cancer	0.000742	0.00852	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00074	0.0085	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—lymph node—head and neck cancer	0.000738	0.0126	CbGeAlD
Dinoprost Tromethamine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000736	0.00845	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Hydroxyurea—head and neck cancer	0.000734	0.00843	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Vinblastine—head and neck cancer	0.000716	0.00822	CcSEcCtD
Dinoprost Tromethamine—Pain—Hydroxyurea—head and neck cancer	0.000706	0.00811	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000681	0.00781	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Vinblastine—head and neck cancer	0.000667	0.00766	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—head—head and neck cancer	0.000662	0.0114	CbGeAlD
Dinoprost Tromethamine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000653	0.00749	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vinblastine—head and neck cancer	0.00065	0.00746	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Docetaxel—head and neck cancer	0.000635	0.00728	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Fluorouracil—head and neck cancer	0.000631	0.00724	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Fluorouracil—head and neck cancer	0.00062	0.00712	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Vinblastine—head and neck cancer	0.00062	0.00711	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Fluorouracil—head and neck cancer	0.000613	0.00703	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000608	0.00698	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vinblastine—head and neck cancer	0.000599	0.00687	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Hydroxyurea—head and neck cancer	0.000593	0.0068	CcSEcCtD
Dinoprost Tromethamine—Infection—Fluorouracil—head and neck cancer	0.000591	0.00678	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Fluorouracil—head and neck cancer	0.00058	0.00666	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vinblastine—head and neck cancer	0.000576	0.00661	CcSEcCtD
Dinoprost Tromethamine—Headache—Vinblastine—head and neck cancer	0.000567	0.00651	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000565	0.00649	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Fluorouracil—head and neck cancer	0.000555	0.00638	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Docetaxel—head and neck cancer	0.000548	0.00629	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Hydroxyurea—head and neck cancer	0.000546	0.00627	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Docetaxel—head and neck cancer	0.000545	0.00626	CcSEcCtD
Dinoprost Tromethamine—Chills—Docetaxel—head and neck cancer	0.000542	0.00622	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vinblastine—head and neck cancer	0.000538	0.00617	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Fluorouracil—head and neck cancer	0.000534	0.00613	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Fluorouracil—head and neck cancer	0.00053	0.00608	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Fluorouracil—head and neck cancer	0.000528	0.00607	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Hydroxyurea—head and neck cancer	0.000525	0.00603	CcSEcCtD
Dinoprost Tromethamine—Rash—Hydroxyurea—head and neck cancer	0.000521	0.00598	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Hydroxyurea—head and neck cancer	0.00052	0.00597	CcSEcCtD
Dinoprost Tromethamine—Headache—Hydroxyurea—head and neck cancer	0.000517	0.00594	CcSEcCtD
Dinoprost Tromethamine—Back pain—Docetaxel—head and neck cancer	0.000509	0.00584	CcSEcCtD
Dinoprost Tromethamine—Pain—Fluorouracil—head and neck cancer	0.000508	0.00583	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Docetaxel—head and neck cancer	0.000505	0.0058	CcSEcCtD
Dinoprost Tromethamine—Nausea—Hydroxyurea—head and neck cancer	0.000491	0.00563	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00049	0.00562	CcSEcCtD
Dinoprost Tromethamine—Syncope—Docetaxel—head and neck cancer	0.000471	0.00541	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Fluorouracil—head and neck cancer	0.00047	0.00539	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Docetaxel—head and neck cancer	0.000462	0.0053	CcSEcCtD
Dinoprost Tromethamine—Cough—Docetaxel—head and neck cancer	0.000459	0.00527	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Docetaxel—head and neck cancer	0.000455	0.00523	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Docetaxel—head and neck cancer	0.000454	0.00521	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Docetaxel—head and neck cancer	0.000448	0.00514	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000438	0.00503	CcSEcCtD
Dinoprost Tromethamine—Infection—Docetaxel—head and neck cancer	0.000426	0.00489	CcSEcCtD
Dinoprost Tromethamine—Shock—Docetaxel—head and neck cancer	0.000422	0.00485	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Fluorouracil—head and neck cancer	0.000421	0.00483	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Docetaxel—head and neck cancer	0.000419	0.00481	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Fluorouracil—head and neck cancer	0.000407	0.00467	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Docetaxel—head and neck cancer	0.000401	0.0046	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Fluorouracil—head and neck cancer	0.000393	0.00451	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Docetaxel—head and neck cancer	0.000385	0.00442	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Docetaxel—head and neck cancer	0.000383	0.00439	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Docetaxel—head and neck cancer	0.000381	0.00438	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Fluorouracil—head and neck cancer	0.000378	0.00434	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—KISS1—head and neck cancer	0.000378	0.00257	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Fluorouracil—head and neck cancer	0.000375	0.0043	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Fluorouracil—head and neck cancer	0.000374	0.0043	CcSEcCtD
Dinoprost Tromethamine—Headache—Fluorouracil—head and neck cancer	0.000372	0.00427	CcSEcCtD
Dinoprost Tromethamine—Pain—Docetaxel—head and neck cancer	0.000367	0.00421	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000363	0.00248	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000363	0.00248	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000363	0.00248	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00036	0.00245	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Docetaxel—head and neck cancer	0.000354	0.00406	CcSEcCtD
Dinoprost Tromethamine—Nausea—Fluorouracil—head and neck cancer	0.000353	0.00405	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000351	0.00403	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KISS1—head and neck cancer	0.00035	0.00239	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000346	0.00236	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KISS1—head and neck cancer	0.000343	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KISS1—head and neck cancer	0.000343	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—NAT2—head and neck cancer	0.000342	0.00233	CbGpPWpGaD
Dinoprost Tromethamine—Body temperature increased—Docetaxel—head and neck cancer	0.000339	0.00389	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Docetaxel—head and neck cancer	0.000339	0.00389	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000328	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GRP—head and neck cancer	0.000326	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—GRP—head and neck cancer	0.000318	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000317	0.00216	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STAT6—head and neck cancer	0.000316	0.00216	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Docetaxel—head and neck cancer	0.000316	0.00363	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000315	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—GRP—head and neck cancer	0.000311	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—GRP—head and neck cancer	0.000311	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.00031	0.00211	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Docetaxel—head and neck cancer	0.000308	0.00353	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KISS1—head and neck cancer	0.000307	0.00209	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000305	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Docetaxel—head and neck cancer	0.000304	0.00348	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000301	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000301	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—DPYD—head and neck cancer	0.0003	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000295	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Docetaxel—head and neck cancer	0.000294	0.00337	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000292	0.00199	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000289	0.00197	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—GRP—head and neck cancer	0.000289	0.00197	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—YAP1—head and neck cancer	0.000285	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Docetaxel—head and neck cancer	0.000284	0.00326	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—GRP—head and neck cancer	0.000282	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—GRP—head and neck cancer	0.000282	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—YAP1—head and neck cancer	0.00028	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KISS1—head and neck cancer	0.000277	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Docetaxel—head and neck cancer	0.000273	0.00313	CcSEcCtD
Dinoprost Tromethamine—Rash—Docetaxel—head and neck cancer	0.000271	0.00311	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Docetaxel—head and neck cancer	0.00027	0.0031	CcSEcCtD
Dinoprost Tromethamine—Headache—Docetaxel—head and neck cancer	0.000269	0.00309	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000261	0.00178	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000258	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000256	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Docetaxel—head and neck cancer	0.000255	0.00293	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GRP—head and neck cancer	0.000253	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT6—head and neck cancer	0.000245	0.00167	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000242	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000241	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GRP—head and neck cancer	0.000228	0.00155	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT6—head and neck cancer	0.000221	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—YAP1—head and neck cancer	0.000217	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—UROD—head and neck cancer	0.000215	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000214	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000214	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000209	0.00143	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000209	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KISS1—head and neck cancer	0.000207	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000203	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000203	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KISS1—head and neck cancer	0.000203	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KISS1—head and neck cancer	0.000203	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000199	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000199	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IL2—head and neck cancer	0.000199	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000197	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—YAP1—head and neck cancer	0.000196	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000193	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000187	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000176	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000173	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—TYMS—head and neck cancer	0.000171	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GRP—head and neck cancer	0.00017	0.00116	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—GSTM1—head and neck cancer	0.000169	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—head and neck cancer	0.000169	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GRP—head and neck cancer	0.000167	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GRP—head and neck cancer	0.000167	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT6—head and neck cancer	0.000165	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000163	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT6—head and neck cancer	0.000162	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT6—head and neck cancer	0.000162	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—IL2—head and neck cancer	0.000162	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—GPX1—head and neck cancer	0.000162	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CYP1A1—head and neck cancer	0.00016	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00016	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—MAPK3—head and neck cancer	0.00016	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—MAPK1—head and neck cancer	0.000152	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL2—head and neck cancer	0.000147	0.001	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—YAP1—head and neck cancer	0.000146	0.000998	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—YAP1—head and neck cancer	0.000143	0.000977	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—YAP1—head and neck cancer	0.000143	0.000977	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—PIK3CA—head and neck cancer	0.000132	0.000899	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000132	0.000897	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IL2—head and neck cancer	0.000131	0.000894	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—head and neck cancer	0.000128	0.00087	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOTCH1—head and neck cancer	0.000126	0.00086	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—IL2—head and neck cancer	0.000126	0.000856	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—HRAS—head and neck cancer	0.000122	0.000832	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—MAPK3—head and neck cancer	0.000118	0.000806	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL2—head and neck cancer	0.000114	0.000777	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—IL2—head and neck cancer	0.000113	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—MAPK1—head and neck cancer	0.000112	0.000767	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EGFR—head and neck cancer	0.000112	0.000767	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—head and neck cancer	0.000111	0.00076	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—AKT1—head and neck cancer	0.000108	0.000734	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000107	0.000733	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—MAPK3—head and neck cancer	0.000105	0.000719	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL2—head and neck cancer	0.000103	0.000701	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—MAPK1—head and neck cancer	0.0001	0.000684	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOTCH1—head and neck cancer	9.79e-05	0.000667	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PIK3CA—head and neck cancer	9.76e-05	0.000665	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—head and neck cancer	9.53e-05	0.00065	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—MAPK3—head and neck cancer	9.16e-05	0.000625	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	9.12e-05	0.000622	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HRAS—head and neck cancer	9.03e-05	0.000616	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NAT2—head and neck cancer	8.91e-05	0.000608	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOTCH1—head and neck cancer	8.83e-05	0.000602	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—AKT1—head and neck cancer	8.78e-05	0.000598	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—MAPK1—head and neck cancer	8.72e-05	0.000594	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—head and neck cancer	8.72e-05	0.000594	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—PIK3CA—head and neck cancer	8.71e-05	0.000593	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL2—head and neck cancer	8.69e-05	0.000592	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—head and neck cancer	8.47e-05	0.000577	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCND1—head and neck cancer	8.47e-05	0.000577	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—head and neck cancer	8.42e-05	0.000574	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—PIK3CA—head and neck cancer	8.33e-05	0.000568	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTEN—head and neck cancer	8.31e-05	0.000566	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—IL2—head and neck cancer	8.29e-05	0.000565	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—head and neck cancer	8.29e-05	0.000565	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MAPK3—head and neck cancer	8.27e-05	0.000564	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTEN—head and neck cancer	8.17e-05	0.000557	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—head and neck cancer	8.05e-05	0.000549	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKT1—head and neck cancer	7.97e-05	0.000543	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MAPK1—head and neck cancer	7.87e-05	0.000536	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—head and neck cancer	7.86e-05	0.000536	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—DPYD—head and neck cancer	7.82e-05	0.000533	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL2—head and neck cancer	7.69e-05	0.000524	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PIK3CA—head and neck cancer	7.57e-05	0.000516	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL2—head and neck cancer	7.53e-05	0.000513	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL2—head and neck cancer	7.53e-05	0.000513	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—PIK3CA—head and neck cancer	7.52e-05	0.000512	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—YAP1—head and neck cancer	7.42e-05	0.000506	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—head and neck cancer	7.38e-05	0.000503	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	7.32e-05	0.000499	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STAT3—head and neck cancer	7.31e-05	0.000498	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—AKT1—head and neck cancer	7.11e-05	0.000485	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—head and neck cancer	7e-05	0.000477	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—MAPK1—head and neck cancer	6.99e-05	0.000476	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MAPK3—head and neck cancer	6.98e-05	0.000476	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PIK3CA—head and neck cancer	6.83e-05	0.000465	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—head and neck cancer	6.81e-05	0.000464	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL2—head and neck cancer	6.73e-05	0.000459	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MAPK1—head and neck cancer	6.64e-05	0.000453	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—head and neck cancer	6.64e-05	0.000453	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—head and neck cancer	6.6e-05	0.00045	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—head and neck cancer	6.56e-05	0.000448	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH1—head and neck cancer	6.46e-05	0.00044	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—head and neck cancer	6.46e-05	0.00044	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTEN—head and neck cancer	6.34e-05	0.000432	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—head and neck cancer	6.31e-05	0.00043	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—head and neck cancer	6.18e-05	0.000421	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—head and neck cancer	6.18e-05	0.000421	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—head and neck cancer	6.14e-05	0.000419	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL2—head and neck cancer	6.07e-05	0.000414	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MAPK3—head and neck cancer	6.05e-05	0.000412	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—head and neck cancer	6.05e-05	0.000412	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—head and neck cancer	5.92e-05	0.000404	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MAPK1—head and neck cancer	5.88e-05	0.000401	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—head and neck cancer	5.88e-05	0.000401	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PIK3CA—head and neck cancer	5.86e-05	0.0004	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PIK3CA—head and neck cancer	5.77e-05	0.000393	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MAPK1—head and neck cancer	5.76e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MAPK1—head and neck cancer	5.76e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—head and neck cancer	5.76e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—head and neck cancer	5.76e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—head and neck cancer	5.72e-05	0.00039	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTEN—head and neck cancer	5.72e-05	0.00039	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT3—head and neck cancer	5.67e-05	0.000386	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—head and neck cancer	5.62e-05	0.000383	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—head and neck cancer	5.61e-05	0.000382	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—head and neck cancer	5.58e-05	0.00038	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—head and neck cancer	5.58e-05	0.00038	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—head and neck cancer	5.5e-05	0.000375	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PIK3CA—head and neck cancer	5.5e-05	0.000375	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK3—head and neck cancer	5.41e-05	0.000369	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—head and neck cancer	5.33e-05	0.000364	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—head and neck cancer	5.16e-05	0.000352	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK1—head and neck cancer	5.15e-05	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—head and neck cancer	5.15e-05	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT3—head and neck cancer	5.11e-05	0.000348	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—head and neck cancer	5.1e-05	0.000348	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3CA—head and neck cancer	5e-05	0.000341	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—head and neck cancer	5e-05	0.000341	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK3—head and neck cancer	4.88e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—head and neck cancer	4.79e-05	0.000326	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—head and neck cancer	4.72e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—head and neck cancer	4.71e-05	0.000321	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK1—head and neck cancer	4.65e-05	0.000317	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—head and neck cancer	4.65e-05	0.000317	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—head and neck cancer	4.62e-05	0.000315	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—head and neck cancer	4.62e-05	0.000315	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—head and neck cancer	4.59e-05	0.000313	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL2—head and neck cancer	4.54e-05	0.00031	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—head and neck cancer	4.49e-05	0.000306	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—head and neck cancer	4.49e-05	0.000306	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CA—head and neck cancer	4.47e-05	0.000305	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TYMS—head and neck cancer	4.45e-05	0.000304	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL2—head and neck cancer	4.45e-05	0.000303	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL2—head and neck cancer	4.45e-05	0.000303	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—head and neck cancer	4.43e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTM1—head and neck cancer	4.4e-05	0.0003	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—head and neck cancer	4.33e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—head and neck cancer	4.33e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—head and neck cancer	4.32e-05	0.000295	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTEN—head and neck cancer	4.27e-05	0.000291	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GPX1—head and neck cancer	4.22e-05	0.000287	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTEN—head and neck cancer	4.18e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTEN—head and neck cancer	4.18e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP1A1—head and neck cancer	4.17e-05	0.000284	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—head and neck cancer	4.17e-05	0.000284	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—head and neck cancer	4.14e-05	0.000282	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—head and neck cancer	4.08e-05	0.000278	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—head and neck cancer	4.08e-05	0.000278	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CA—head and neck cancer	4.03e-05	0.000275	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—head and neck cancer	3.9e-05	0.000266	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—head and neck cancer	3.86e-05	0.000263	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT3—head and neck cancer	3.82e-05	0.000261	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—head and neck cancer	3.78e-05	0.000258	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—head and neck cancer	3.78e-05	0.000258	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT3—head and neck cancer	3.74e-05	0.000255	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT3—head and neck cancer	3.74e-05	0.000255	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—head and neck cancer	3.73e-05	0.000254	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—head and neck cancer	3.65e-05	0.000249	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—head and neck cancer	3.65e-05	0.000249	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK3—head and neck cancer	3.57e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—head and neck cancer	3.57e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK1—head and neck cancer	3.47e-05	0.000237	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—head and neck cancer	3.47e-05	0.000237	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK1—head and neck cancer	3.4e-05	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK1—head and neck cancer	3.4e-05	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—head and neck cancer	3.4e-05	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—head and neck cancer	3.4e-05	0.000232	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—head and neck cancer	3.29e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—head and neck cancer	3.02e-05	0.000206	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CA—head and neck cancer	2.95e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—head and neck cancer	2.95e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—head and neck cancer	2.92e-05	0.000199	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—head and neck cancer	2.86e-05	0.000195	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—head and neck cancer	2.86e-05	0.000195	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—head and neck cancer	2.79e-05	0.00019	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—head and neck cancer	2.73e-05	0.000186	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—head and neck cancer	2.73e-05	0.000186	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—head and neck cancer	2.48e-05	0.000169	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—head and neck cancer	2.46e-05	0.000168	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—head and neck cancer	2.41e-05	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—head and neck cancer	2.41e-05	0.000164	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTEN—head and neck cancer	2.16e-05	0.000148	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	1.53e-05	0.000104	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—head and neck cancer	1.25e-05	8.5e-05	CbGpPWpGaD
